Cargando…
Safety of Gliadel Implant for Malignant Glioma: Report of Postmarketing Surveillance in Japan
Clinical trial data of Carmustine implant (Gliadel Wafer) in Japanese patients with malignant glioma are limited; thus, we conducted a postmarketing surveillance study to evaluate the safety of Gliadel in real-world clinical practice in Japan. In this postmarketing surveillance study, all patients w...
Autores principales: | NISHIKAWA, Ryo, IWATA, Hisayuki, SAKATA, Yukinori, MURAMOTO, Kenzo, MATSUOKA, Toshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443968/ https://www.ncbi.nlm.nih.gov/pubmed/34092748 http://dx.doi.org/10.2176/nmc.oa.2021-0024 |
Ejemplares similares
-
Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan
por: Iuchi, Toshihiko, et al.
Publicado: (2022) -
A Multicenter Phase I/II Study of the BCNU Implant (Gliadel (®) Wafer) for Japanese Patients with Malignant Gliomas
por: AOKI, Tomokazu, et al.
Publicado: (2014) -
Gliadel wafers in the treatment of malignant glioma: a systematic review
por: Perry, J., et al.
Publicado: (2007) -
Pharmacodynamic analysis of eribulin safety in breast cancer patients using real‐world postmarketing surveillance data
por: Kawamura, Takahisa, et al.
Publicado: (2018) -
Interstitial chemotherapy with biodegradable BCNU (Gliadel(®)) wafers in the treatment of malignant gliomas
por: Bota, Daniela A, et al.
Publicado: (2007)